Screener
Regenxbio RGNX D&A
D&A at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
FAQ
- What is Regenxbio's D&A?
- Regenxbio (RGNX) reported D&A of $3.76M in Q2 2026.
- How has Regenxbio's D&A changed year-over-year?
- Regenxbio's D&A decreased by 3.8% year-over-year, from $3.91M to $3.76M.
- What is the long-term trend for Regenxbio's D&A?
- Over 4 years (2021 to 2025), Regenxbio's D&A has grown at a 13.0% compound annual growth rate (CAGR), from $9.56M to $15.62M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Regenxbio's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude